Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design.

Frontiers in Immunology
Denise A Kaminski, F Eun-Hyung Lee

Abstract

High-performance neutralizing antibody against influenza virus typically recognizes the globular head region of its hemagglutinin (HA) envelope glycoprotein. To-date, approved human vaccination strategies have been designed to induce such antibodies as a sole means of preventing the consequences of this infection. However, frequent amino-acid changes in the HA globular head allow for efficient immune evasion. Consequently, vaccines inducing such neutralizing antibodies need to be annually re-designed and re-administered at a great expense. These vaccines furthermore provide little-to-no immunity against antigenic-shift strains, which arise from complete replacement of HA or of neuraminidase genes, and pose pandemic risks. To address these issues, laboratory research has focused on inducing immunity effective against all strains, regardless of changes in the HA globular head. Despite prior dogma that such cross-protection needs to be induced by cellular immunity alone, several advances in recent years demonstrate that antibodies of other specificities are capable of cross-strain protection in mice. This review discusses the reactivity, induction, efficacy, and mechanisms of antibodies that react with poorly accessible epitopes i...Continue Reading

Citations

Jan 1, 2014·Vaccines·Claudia Maria TrombettaEmanuele Montomoli
Apr 14, 2015·Nanomedicine·Anushree SethYong Taik Lim
Jan 1, 2013·Antiviral Research·Sergei V TillibAlexander L Gintsburg
Feb 6, 2013·Chest·Margarita M Gomez Lorenzo, Matthew J Fenton
Oct 27, 2018·Expert Review of Vaccines·Ye WangBao-Zhong Wang
Jul 14, 2012·The Journal of General Virology·Yohei WatanabeKazuyoshi Ikuta
Dec 12, 2020·International Immunopharmacology·Hyun Jee HanSan Kim
Jan 24, 2021·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Cedric HirzelUNKNOWN Influenza in Transplant Study Group
Sep 27, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Philippe BuchyEskild Petersen
Oct 24, 2021·Immunology and Cell Biology·Hillary A VandervenStephen J Kent

❮ Previous
Next ❯

Methods Mentioned

BETA
phage-display
nuclear translocation
flow cytometry

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.